10 Hot Stocks to Watch — Thursday, October 8, 2026

Rocket Lab jumped 4.91% after NASA tapped it as a potential launch provider for its $30 billion lunar program alongside SpaceX, signaling validation of its Neutron rocket despite unprofitability concerns. Options traders are aggressively bullish, with call-to-put ratio of 4.13 and 15,110 contracts stacked in the $75 October 2026 calls, suggesting conviction above current $73.92 levels. The stock's extreme beta of 3.17 amplifies both the opportunity and downside risk. Watch the $75 strike for technical resistance as Cramer-led commentary continues to pit RKLB against SpaceX leadership.

CrowdStrike fell 4.81% to $265.44 despite earning IDC MarketScape Leader status for endpoint security, signaling profit-taking after a 210% run from 52-week lows. The options market is flashing caution: a 0.51 call-to-put ratio and 10,000+ contracts of put volume across $250–$260 strikes through October suggest institutional hedging ahead of potential consolidation. Watch the $260 support level; heavy October put positioning implies traders expect downside pressure into year-end, though analyst Dan Ives still ranks CRWD among top AI picks.

Moderna surged 4.81% to $196.48 today, outperforming a broader market selloff as healthcare stocks found refuge. The rally comes as the biotech's oncology pipeline—anchored by its Tempus collaboration on personalized neoantigen therapy—gains traction to offset cooling vaccine revenues. Options markets are aggressively bullish, with 6,825 calls printed at the $200 strike and heavy positioning across $210–$220 levels ahead of October 9 expiry, suggesting traders expect a breakout past the stock's 52-week high of $208.90.

Micron Technology jumped 4.06% to $1,088 as veteran analysts reset bullish targets, citing a structural shift away from the company's historic boom-bust memory-chip dependency. The semiconductor name is now being recast as a secular AI play, with Jim Cramer noting long-term customer agreements signaling margin stability. Options markets are pricing aggressive conviction: call volume hit 7.44x puts, with heavy positioning in $1,100–$1,150 calls expiring mid-October, suggesting traders see limited downside near current levels.

Coinbase fell 3.92% to $178.45 as Bitcoin dropped below $83,000 amid a broader crypto selloff, though the options market is flashing contrarian optimism. Heavy call buying—highlighted by 7,279 contracts at the $195 strike expiring October 2026—signals investors are positioning for a rebound above near-term resistance. The U.S. government's $103 million Bitcoin transfer to Coinbase Prime could unlock a catalyst if liquidation begins, while USDC adoption tailwinds and Coinbase Pro's revival offer structural upside. Watch $195 as the key breakeven for call buyers.

Nike slumped 3.64% to $33.87 today, extending pressure from three-year revenue declines and structural headwinds including brand fatigue and market saturation. The apparel giant's decision to obscure China sales disclosure in its latest 10-Q filing has heightened investor concern about the critical geography's performance. Yet options markets show contrarian strength: call volume surged 5,351 contracts on the $35 October 2026 strike, signaling bullish bets that quality product shifts and supply-chain tightening could drive a recovery. Watch the $34–$35 band through year-end.

SoundHound AI fell 3.47% to $5.84 today, extending its slide from a 52-week high of $22.17, though options markets flash contrarian conviction. Call-to-put ratio of 8.94 signals heavy bullish positioning, with notable clustering around $6.0 and $5.5 strikes across October expiries. The divergence reflects investor optimism on OASYS edge deployments in automotive and IoT, even as the stock struggles to regain momentum near support levels established in recent weeks.

Palo Alto Networks dropped 3.42% to $405.57 today, pulling back from near 52-week highs despite strengthening fundamentals in AI-driven security. The Cyderes partnership underscores PANW's Cortex platform momentum, yet analyst commentary flags rich valuation after a decade-long rally that now leaves limited upside visibility. Options flow remains mixed with a 0.75 call-put ratio; heavy put volume at $390 (Oct 2026) and call interest above $420 suggest traders are hedging downside while maintaining bullish positioning into Q4 earnings season.

Arm Holdings fell 2.71% today as a federal trial over billions in disputed royalty payments with Qualcomm intensifies, adding legal risk to a stock already pricing in AI tailwinds. The chipmaker's 3.78 beta amplifies every market tremor—YTD gains of 187% have left little room for disappointment. Options markets are hedging risk: put volume at the $100 strike (Oct. 2026) is running 5,514 contracts, while call positioning remains measured. Watch the trial outcome and Q2 earnings guidance; any royalty headwinds could trigger a sharp unwind toward $280–$290 support.

Eli Lilly gained 2.7% to $1188.72, outperforming a softer market as healthcare stocks bucked broader weakness. Options traders are aggressively positioning for upside, with a 11.46 call-to-put ratio and over 1,300 contracts stacked in the $1250 strike expiring October 2026—well above current levels. Jim Cramer's recent endorsement over Novo Nordisk and LLY's valuation premium relative to peers underscore investor conviction. Watch $1250 resistance; a break above it could trigger further call spreads.